LelandShapiroMD

Infectious Disease • Aurora, CO

Associate Professor, Medicine, University of Colorado School of Medicine

Join to view full profile

Dr. Shapiro is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Shapiro's full profile

Already have an account?

Office
12605 E 16th Ave
Aurora, CO 80045
Phone+1 720-848-0000

Education & Training

Tufts Medical CenterFellowship, Infectious Disease, 1990 - 1994
University of North Carolina HospitalsFellowship, Infectious Disease, 1987 - 1989
University of North Carolina HospitalsInternship, Internal Medicine, 1986 - 1987
University of Massachusetts Medical SchoolClass of 1986

Certifications & Licensure

CO State Medical License 1996 - 2025
NC State Medical License 1989 - 1992
American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

1 citations
Glucocorticoids as a risk factor for infection and adverse outcomes in non-HIV and non-transplant patients with cryptococcal meningitis.
Luke Kim, Carolina Ferraz, Michaele Francesco Corbisiero, Sarah Gorvetzian, Carlos Franco-Paredes
Mycoses. 2024-03-01
Diabetes Mellitus Type 2 as a Risk Factor and Outcome Modifier for Cryptococcosis in HIV Negative, Non-transplant Patients, a Propensity Score Match Analysis.
Vanessa M Kung, Carolina Ferraz, Matthew Kennis, Carlos Franco-Paredes, Jose Tuells
Current Microbiology. 2023-10-31
9 citations
Previous corticosteroid exposure associates with an increasedpneumonia mortality among HIV-negative patients: a global research network with a follow-up multicenter ca...
Lilian Vargas Barahona, Kyle C Molina, Laura C Pedraza-Arévalo, Stefan Sillau, Alex Tagawa
Therapeutic Advances in Infectious Disease. 2023-03-14

Press Mentions

Diagnostic Utility of a Ferritin-to-Procalcitonin Ratio to Differentiate Patients with COVID-19 from Those with Bacterial Pneumonia: A Multicenter StudyOctober 20th, 2020